abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeblueskyburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfilterflaggenderglobeglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptriangletwitteruniversalitywebwhatsappxIcons / Social / YouTube

このページは 日本語 では利用できません。English で表示されています

記事

2007年2月2日

著者:
Apiradee Treerutkuarkul, Bangkok Post

WHO raps compulsory licensing plan [Thailand]

The [WHO] yesterday cautioned Thailand over its move to adopt compulsory licensing for producing generic versions of heart disease and anti-Aids drugs…WHO director-general Margaret Chan…said she truly felt that the pharmaceutical industry was part of the solution to better drug access and that the government should open negotiations with drug firms over the issue… [refers to Abbott Laboratories & Bristol-Myers Squibb]

タイムライン